Adjunctive antioxidants for schizophrenia showed no clear difference in adverse effects: 1. Serious (any time point) ‐ any serious adverse… compared with placebo (low certainty).
It is very uncertain whether FLUPHENAZINE DECANOATE changes death compared with PLACEBO (very low certainty).
It is very uncertain whether FLUPHENAZINE DECANOATE changes relapse compared with PLACEBO (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether FLUPHENAZINE DECANOATE changes leaving the study early compared with PLACEBO (very low certainty).
It is very uncertain whether FLUPHENAZINE DECANOATE changes extrapyramidal adverse effects ‐ tardive dyskinesia compared with PLACEBO (very low certainty).
It is very uncertain whether PERPHENAZINE changes global state: Change over time ‐ no better or deterioration ‐ short… compared with PLACEBO (very low certainty).
It is very uncertain whether PERPHENAZINE changes mental state: Relapse ‐ short term clinical diagnosis compared with PLACEBO (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether PERPHENAZINE changes adverse events: extrapyramidal adverse effects ‐ dystonia ‐ short term compared with PLACEBO (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Lithium as sole treatment showed no clear difference in response to treatment clinically relevant response as defined by the… compared with placebo (low certainty).
Adjunctive lithium + antipsychotics may leads to higher response to treatment clinically relevant response as defined by the… compared with placebo/no adjunctive treatment + antipsychotics (low certainty).
It is very uncertain whether adjunctive lithium + antipsychotics changes acceptability of treatment leaving early due to any reason compared with placebo/no adjunctive treatment + antipsychotics (very low certainty).
Adjunctive lithium + antipsychotics showed no clear difference in clinically significant response on depressive symptoms at least 50%… compared with placebo/no adjunctive treatment + antipsychotics (low certainty).
Adjunctive lithium + antipsychotics showed no clear difference in clinically significant response on manic symptoms at least 50%… compared with placebo/no adjunctive treatment + antipsychotics (low certainty).